2 completed, 1 recruiting, 1 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Recruiting 1, Terminated 1 |
Follow Multihance: new trials by email Literature Review of Multihance trials Research Report on Multihance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases Gadoxetate disodium, Gadobenate dimeglumine - Oligometastatic Disease, Liver Metastases | Phase 4 | Terminated | University of Colorado, Denver | 10 | 2021-06-22 | 2026-09-25 |
| Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years Motor Tests, Cognitive Tests, Unenhanced-MRI of the brain - Motor Function, Cognitive Function | Phase 4 | Recruiting | Guerbet | 2076 | 2021-03-24 | 2026-01-22 |
| Multihance at 3 Tesla (3T) in Brain Tumors Multihance, Arm 2 - Magnevist - Brain Tumor | Phase 4 | Completed | Bracco Diagnostics, Inc | 46 | 2006-11-01 | 2020-11-05 |
| A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain Multihance - Brain Pathology | Phase 4 | Completed | Bracco Diagnostics, Inc | 114 | 2006-05-01 | 2008-01-23 |
Colorectal Neoplasms (2) · Brain Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Neuroendocrine Tumors (1) · Prostatic Neoplasms (1)
Bracco Diagnostics, Inc (2) · Guerbet (1) · University of Colorado, Denver (1)
United States (4) · Brazil (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Russia (1) · South Korea (1)
Barry Hogstrom, M. D. (1) · Gianpaolo Priovano, M.D. (1) · Nikhil Madhuripan, MD (1)
P30CA046934 (1)